Summit Securities Group’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
Other funds holding AGL
CDR
NPCM
CP
Summit Securities Group's AGL Position: Q3 2025 in Review
Summit Securities Group sold out of Agilon Health (AGL) in Q3 2025, closing a stake of 1,880 shares — an estimated $108K sold.
Summit Securities Group first reported a position in AGL in Q4 2022 and held it in 2 quarters. The position peaked at $131K in Q4 2022. 190 funds tracked by Wall St. Rank hold AGL as of Q3 2025.
- Summit Securities Group reported no remaining Agilon Health position as of Q3 2025 after selling out during the quarter.
- Summit Securities Group sold 1,880 Agilon Health shares in Q3 2025, an estimated $108K.
- Summit Securities Group first reported a position in Agilon Health in Q4 2022 and held it in 2 quarters.
- Summit Securities Group's Agilon Health position peaked at $131K in Q4 2022.
- 190 funds tracked by Wall St. Rank held Agilon Health as of Q3 2025.
Based on Summit Securities Group's 13F filing for Q3 2025, filed 13 Nov 2025.